发明名称 |
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING HCV INFECTION |
摘要 |
The inventors examined an anti-HCV effect of an SPT inhibitor and/or interferon using an HCV subgenomic replicon cell FLR3-1 or an HCV infected chimeric mouse. As a result, it was found that myriocin, an SPT inhibitor, or a compound represented by the formula (III) can be a novel therapeutic agent for HCV infection and that a higher HCV replication inhibitory effect can be obtained by concomitantly using the SPT inhibitor and interferon.
|
申请公布号 |
KR20090021163(A) |
申请公布日期 |
2009.02.27 |
申请号 |
KR20087030189 |
申请日期 |
2008.12.11 |
申请人 |
TOKYO METROPOLITAN ORGANIZATION FOR MEDICAL RESEARCH;CHUGAI SEIYAKU KABUSHIKIKAISHA |
发明人 |
KOHARA MICHINORI;UMEHARA TAKUYA;SUDO MASAYUKI |
分类号 |
A61K31/197;A61K38/21;A61P1/16 |
主分类号 |
A61K31/197 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|